We are committed to providing a website that is accessible to the widest possible audience. To do so, we are actively working with consultants to update the website by increasing its accessibility and usability by persons who use assistive technologies
such as automated tools, keyboard-only navigation, and screen readers.
We are working to have the website conform to the relevant standards of the Section 508 Web Accessibility Standards developed by the United States Access Board, as
well as the World Wide Web Consortium's (W3C) Web Content Accessibility Guidelines 2.1. These standards and guidelines explain how to make web content more accessible for people with disabilities. We believe that conformance with these standards and
guidelines will help make the website more user friendly for all people.
Our efforts are ongoing. While we strive to have the website adhere to these guidelines and standards, it is not always possible to do so in all areas of the website.
If, at any time, you have specific questions or concerns about the accessibility of any particular webpage, please contact WebsiteAccess@tenethealth.com so that we may be of assistance.
Children’s Hospital of Michigan has been at the forefront of research on neurological protection, preservation and treatment of neonates.
Seetha Shankaran, M.D. neonatologist at the Children’s Hospital of Michigan was the principal investigator of the 1st randomized
controlled trial of whole body cooling for neonatal hypoxic ischemic encephalopathy (HIE). Considered a pioneer in finding effective methods for protecting HIE-affected newborns, she led a landmark 2005 study in the New England Journal of Medicine
to help make the 72-hour “cooling blanket” procedure the standard of care in treating this condition. Several of her subsequent papers in the New England Journal of Medicine and JAMA have further tested the optimization of cooling therapy
in newborns and long term outcomes of cooled infants. She was also the first author in the publications which have validated a scoring system for MRI as a prognostic marker for neonatal encephalopathy.
Children’s Hospital of Michigan has also been a site for innovative multicenter research trials of stem cell therapy in HIE and the Gene Target study in preterm intracranial hemorrhage. Neonatologists, Dr. Sanjay Chawla and Dr. Shankaran are currently leading a proposed randomized multicenter trial of cooling therapy in mild HIE. Dr. Sidartha Tan has established a Translational Research Laboratory with a rabbit model of cerebral palsy in rabbits, which serves as a platform for mechanistic studies in HIE and inflammatory brain injury. His team has investigated preventive and restorative therapies,
including tetrahydrobiopterin supplementation and human umbilical cord blood cells. Dr. Girija Natarajan is a member of the multicenter Children’s
Hospitals Neonatal Consortium HIE focus group and has published extensively in the area.
"This is a dialog window which overlays the main content of the page and plays an embedded YouTube video. Pressing the Close Modal button at the bottom of the modal or pressing the Escape key will close the modal and bring you back to where you were on the page.